IFN-γ activates the C3G/Rap1 signaling pathway

Journal of Immunology

Volumn 164, Issue 4, 2000, Pages 1800-1806

  Alsayed, Yazan ^a   Uddin, Shahab ^a   Ahmad, Sarfraz ^a   Majchrzak, Beata ^b   Druker, Brian J ^c   Fish, Eleanor N ^b   Platanias, Leonidas C ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b UNIVERSITY OF TORONTO   (Canada)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; RECOMBINANT ALPHA INTERFERON; RECOMBINANT GAMMA INTERFERON;

ARTICLE; CANCER IMMUNOLOGY; CELL GROWTH; CONTROLLED STUDY; GROWTH INHIBITION; GROWTH REGULATION; HUMAN; HUMAN CELL; IMMUNOMODULATION; LEUKEMIA CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TARGET CELL;

EID: 0034652014     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.164.4.1800     Document Type: Article

References (55)

1. Petska, S., J. A. Langer, K. C. Zoon K. C., and C. E. 1987. Interferons and their actions. Annu. Rev. Biochem. 56:727.
2. Darnell, J. E., I. M. Kerr, and G. R. Stark. 1994. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular proteins. Science 264:1415.
3. Stark, G. R., I. M. Kerr, B. R. G. Williams, R. H. Silverman, and R. D. Schreiber. 1998. How cells respond to interferons. Annu. Rev. Biochem. 67:227.
4. Uddin, S., L. Yenush, X.-J. Sun, M. E. Sweet, M. F. White, and L. C. Platanias, 1995. Interferon a engages the insulin receptor substrate-1 to associate with the phosphatidylinositol 3′-kinase. J. Biol Chem. 270:15938.
5. Platanias, L. C., S. Uddin, A. Vetter, X.-J. Sun, and M. F. White. 1996. The type 1 interferon receptor mediates tyrosine phosphorylation of insulin receptor substrate-2. J. Biol. Chem. 271:278.
6. Uddin, S., E. N. Fish, D. Sher, C. Gardziola, M. F. White, and L. C. Platanias. 1997. Activation of the phosphatidylinositol 3′-kinase serine kinase by interferon a. J. Immunol. 158:2390.
7. Uddin, S., E. N. Fish, D. Sher, C. Gardziola, O. R. Colamonici, M. Kellum, P. M. Pitha, M. F. White, and L. C. Platanias. 1997. The IRS-pathway operates distinctively from the Stat-pathway in hematopoietic cells and transduces common and distinct signals during engagement of the insulin or interferon α receptors. Blood 90:2574.
8. Ahmad, S., Y. Alsayed, B. J. Druker, and L. C. Platanias. 1997. The type I interferon receptor mediates tyrosine phosphorylation of the CrkL adaptor protein. J. Biol. Chem. 272: 29991.
9. Fish, E. N., S. Uddin, M. Korkmaz, B. Majchrzak, B. J. Druker, and L. C. Platanias. 1999. Activation of a CrkL-Stat5 signaling complex by type 1 interferons. J. Biol. Chem. 274:571
10. Stancato, L. F., M. Sakatsume, M. David, P. Dent, F. Doing, E. F. Petricoin, J. J. Krolewski, O. Silvennoinen, P. Saharinen, et al. 1997. β-Interferon and oncostatin M activate Raf-1 and mitogen-activated protein kinase through a JAK1-dependent pathway. Mol. Cell. Biol. 17:3833.
11. Ingham, R. J., D. L. Krebs, S. M. Barbazuk, C. W. Turck, H. Hirai, M. Matsuda, and M. R. Gold. 1996. B cell antigen receptor signaling induces the formation of complexes containing the Crk adapter proteins. J. Biol. Chem. 271:32306.
12. Sawasdikosol, S., K. S. Ravichandran, K. Kay Lee, J.-H. Chang, and S. J. Burakoff. 1995. Crk interacts with tyrosine-phosphorylated p116 upon T cell activation. J. Biol. Chem. 270:2893.
13. Reedquist, K. A., T. Fukazawa, G. Panchamoorthy, W. Y. Langdom, S. E. Shoelson, B. J. Druker, and H. Band. 1996. Stimulation through the T cell receptor induces Cbl association with Crk proteins and the guanine exchange protein C3G. J. Biol. Chem. 271:8435.
14. Smit, L., G. Van De Horst, and J. Borst. 1996. Sos. Vav, and C3G participate in B cell receptor-induced signaling pathways and differentially associate with Shc-Grb2, Crk, and CrkL adaptor. J. Biol. Chem. 271:8564.
15. Gotoh, T., S. Hattori, S. Nakamura, H. Kitayama, M. Noda, Y. Takai, K. Kaihuchi, H. Matsui, O. Hatase, H. Takahashi, et al. 1995. Identification of Rap1 as a target for the Crk SH3 domain-binding guanine nucleotide releasing factor C3G. Mol. Cell. Biol. 15:6746.
16. Cook, S., B. Rubinfeld, I. Albert, and F. McCormick. 1993, RapV 12 antagonizes Ras-dependent activation of ERK1 and ERK2 by LPA and EGF in Rat-1 fibroblasts. EMBO J. 12:3475.
17. Kitayama, H., Y. Sugimoto, T. Matsuzaki, Y. Ikawa, and M. Noda. 1989. A ras-related gene with transformation suppressor activity. Cell 56:77.
18. Kitayama, H., T. Matsuzaki, Y. Ikawa, and M. Noda. 1990. Genetic analysis of the Kirsten-ras-revertant 1 gene: potentiation of its tumor suppressor activity by specific point mutations. Proc. Natl. Acad. Sci. USA 87:4284.
19. Uddin, S., A. Chamdin, and L. C. Platanias. 1995 Interaction of the transcriptional activator Stat-2 with the type I interferon receptor. J. Biol. Chem. 270: 24627.
20. Yetter, A., S. Uddin, J. J. Krolewski, H. Jiao, T. Yi, and L. C. Platanias. 1995. Association of the interferon-dependent tyrosine kinase Tyk-2 with the hematopoietic cell phosphatase. J. Biol. Chem. 270:18179.
21. Heaney, C., K. Kolibaba, A. Bhat, T. Oda, S. Ohno, S. Fanning, and B. J. Druker. 1997. Direct binding of CRKL to BCR-ABL is not required for BCR-ABL transformation. Biol. 89:297.
22. +-mediated activation of Rap1 in human platelets. EMBO J. 16:252.
23. Reedquist, K. A., and J. L. Bos. 1998. Costimulation through CD28 suppresses T cell receptor-dependent activation of the Ras-like small GTPase Rap1 in human T lymphocytes. J. Biol. Chem. 273:4494.
24. M'Rabet, L., P. Coffer, F. Zwartkruis, B. Franke, A. W. Segal, L. Keonderman, and J. L. Bos. 1998. Activation of the small GTPase rap1 in human neutrophils. Blood 92:2133.
25. Nason-Burchenal, K., D. Gandini, M. Botto, J. Allopenna, J. R. C. Seale, N. C. P. Cross, J. M. Goldman, E. Dmitrovsky, and P. P. Pandolfi. 1996. Interferon augments PML and PML/RAR α expression in normal myeloid and acute promyelocytic cells and cooperates with all-trans retinoic acid to induce maturation of a retinoid-resistant promyelocytic cell line. Blood 88:3926.
26. Andoniou, C. E., C. B. F. Thien, and W. Y. Langdon. 1996. The two major sites of cbl tyrosine phosphorylation in abl-transformed cells select the crkL SH2 domain. Oncogene 12:1981.
27. Koval, P., M. Karas, Y. Zick, and D. LeRoith. 1998. Interplay of the proto-oncogene proteins CrkL and CrkII in insulin-like growth factor-1 receptor-mediated signal transduction. J. Biol. Chem. 273:14780.
28. Meinke, A., F. Barahmand-Pour, S. Wohrl, D. Stoiber, and T. Decker. 1996. Activation of different Stat5 isoforms contributes to cell-type-restricted signaling in response to interferons. Mol. Cell. Biol. 16:6937.
29. Blake, T. J., M. Shapiro, H. C. Morse, and W. Y. Langdon. 1991. The sequences of the human and mouse c-cbl proto-oncogenes show v-cbl was generated by a large truncation encompassing a proline-rich domain and a leucine zipper-like motif. Oncogene 6:653.
30. Blake, T. J., K. G. Heath, and W. Y. Langdon. 1993. The truncation that generated the v-cbl oncogene reveals an ability for nuclear transport, DNA binding and acute transformation. EMBO J. 12:2017.
31. Wang, Y., Y. Yeung, W. Langdon, and E. R. Stanley. 1995. c-Cbl is transiently tyrosine-phosphorylated, ubiquinated and membrane-targeted following CSF-1 stimulation of macrophages. J. Biol. Chem. 271:17.
32. Odai, H., K. Sasaki, A. Iwamatsu, Y. Hanazono, T. Tanaka, K. Mitani, Y. Yazaki, and H. Hirai. 1995. The protooncogene product c-Cbl becomes tyrosine phosphorylated by stimulation with GM-CSF or Epo and constitutively binds to the SH3 domain of Grb2/Ash in human hematopoietic cells. J. Biol. Chem. 270: 10800.
33. Rivero-Lezcano, O. M., J. H. Sameshima, A. Marcilla, and K. C. Robbins. 1994. Physical association between Src homology 3 elements and the protein product of the c-cbl proto-oncogene. J. Biol. Chem. 269:17363.
34. cbl is a major substrate of tyrosine phosphorylation upon B cell antigen receptor stimulation and interacts in vivo with Fyn and Syk tyrosine kinases. Grb2 and Shc adaptors, and the p85 subunit of phosphatidyl-inositol 3-kinase. J. Biol. Chem. 271:3187.
35. Sattler, M., Salgia, R., Shrikhande, G., Verma, S., Uemura, N., Law, S. F., Golemis, E. A., and Griffin, J. D. 1997. Differential signaling after betal integrin ligation is mediated through binding of CRKL to p 120(CBL) and p110(HEF1). J. Biol. Chem. 272:14320.
36. Meisner, H., and M. P. Czech. 1995. Coupling of the proto-oncogene product c-Cbl to the epidermal growth factor receptor. J. Biol. Chem. 270:25332.
37. cbl is a cytosolic adapter protein that associates with phosphoinositide 3-kinase in response to epidermal growth factor in PC12 and other cells. J. Biol. Chem. 271:563.
38. Tanaka, S., L. Neff, R. Baron, and J. B. Levy. 1995. Tyrosine phosphorylation and translocation of the c-Cbl protein after activation of tyrosine kinase signaling pathways. J. Biol. Chem. 270:14347.
39. Donovan, J. A., R. L. Wange, W. Y. Langdon, and L. E. Samelson. 1994. The protein product of the c-cbl protooncogene is the 120 kDa tyrosine phosphorylated protein in Jurkat cells activated via the T cell antigen receptor. J. Biol. Chem. 269:22921.
40. Meisner, H., B. R. Conway, D. Hartley, and M. P. Czech. 1995. Interactions of CbI with Grb-2 and phosphatidylinositol 3′-kinase in activated Jurkat cells. J. Biol. Chem. 15:3571.
41. Bos, J. L. 1998. All in the family? New insights and questions regarding interconnectivity of Ras, Rap1 and Ral. EMBO J. 17:6776.
42. Mcleod, S. J., R. J. Ingham, J. L. Bos, T. Kurosaki, and M. R. Gold. 1998. Activation of the Rap1 GTPase by the B cell antigen receptor. J. Biol. Chem. 273:29218.
43. Boussiotis, V. A., G. J. Freeman, A. Berezovskaya, D. L. Barber, and L. M. Nadler. 1997. Maintenance of human T cell anergy: blocking of IL-2 gene transcription by activated Rap1. Science 278:124.
44. Kitayama, H., Y. Sugimoto, T. Matsuzaki, Y. Ikawa, and M. Noda. 1989. A ras-related gene with transformation suppressor activity. Cell 56:77.
45. Zwartkruis, F. J., R. M. F. Wolthuis, N. M. J. M. Nabben, B. Franke, J. L. Bos. 1998. Extracellular signal-regulated activation of Rap1 fails to interfere in Ras effector signalling. EMBO J. 77:5905.
46. Platanias, L. C., S. Uddin, E. Bruno, M. Korkmaz, S. Ahmad, Y. Alsayed, D. Van Den Berg, B. J. Druker, A. Wickrema, and R. Hoffman. 1999. CrkL and CrkII participate in the generation of the growth inhibitory effects of interferons on primary hematopoietic progenitors. Exp. Hematol. 27:1315.
47. Chin, Y. E., M. Kitagawa, W. C. Su, Z. H. You, Y. Iwamoto, and X.-Y. Fu. 1996. Cell growth arrest and induction of cyclin-dependent kinase inhibitor p21 WAF1/ CIP1 mediated by STAT1. Science 272:719.
48. Bromberg, J. F., C. M. Horvath, Z. Wen, R. D. Schreiber, and J. E. Darnell, Jr. 1996. Transcriptionally active Stat1 is required for the antiproliferative effects of both interferon-α and interferon-γ. Proc. Natl. Acad. Sci. USA 93:7673.
49. Sakatsume, M., L. F. Stancalo, M. David, O. Silvennoinen, P. Saharinen, J. Pierce, A. C. Larner, and D. S. Finbloom. 1998. Interferon-γ activation of Raf-1 is Jak1-dependent and p21ras-independent. J. Biol. Chem. 273:3021.
50. York, R. D., H. Tao, T. Dillon, C. L. Ellig, S. P. Eckert, E. W. McCleskey, and P. J. S. Stock. 1998. Rap1 mediates sustained MAP kinase activation induced by nerve growth factor. Nature 392:622.
51. Spaargaren, M., and J. R. Bischoff. 1994. Identification of the guanine nucleotide dissociation stimulator for Ral as a putative effector molecule pf R-ras, H-ras, K-ras and Rap. Proc. Natl. Acad. Sci. USA 91:12609.
52. Kishida, S., S. Koyama, K. Matsubara, M. Kishida, Y. Matsuura, and A. Kikuchi, 1997. Colocalization of Ras and Ral on the membrane is required for Ras-dependent ral activation through RaIGDP dissociation stimulator. Oncogene 15: 2899.
53. Wolthuis, R. M. F., B. Bauer, L. J. vant' Veerm, A. M. de Vries-Smits, R. H. Cool, M. Spaargen, A. Wittinghofer, B. M. Burgering, and J. L. Bos. 1996. RalGDS-like factor (R1f) is a novel Ras and Rap1A-associating protein. Oncogene 13:353.
54. Wolthuis, R. M. F., N. D. de Ruiter, R. H. Cool, and J. L. Bos. 1997. Stimulation of gene induction and growth by the Ras effector RIf. EMBO J. 16:6748.
55. Serebriskii, I., J. Estojak, G. Sonoda, J. R. Testa, and E. A. Golemis. 1997. Association of Krev-rapla with krit1, a novel ankyrin repeat-containing protein encoded by gene mapping to 7q21-22. Oncogene 15:1043.